[1] Walerfield MD.Epidermal growth factor and related molecules.Lancet,1989,333(8649):1243-1246.
[2] Carpenter G,Cohen S.Epidermal growth factor.J Biol Chem,1990,265(14):7709-7712.
[3] 李云春, 谭天秩.表皮生长因子(EGF)与肿瘤的放射性核素显像诊断和治疗.同位素,1999,12(4):222-225.
[4] Rosenthal EL,Kulbersh BD,King T,et al.Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.Mol Cancer Ther,2007, 6(4):1230-1238.
[5] 彭志平,文明,王树斌, 等.胶质瘤表皮牛长因子受体显像的实验研究.重庆医科大学学报,2007,32(5):467-469.
[6] 熊建萍, 项晓军.抗肿瘤新型靶向药物西妥昔单抗.药品评价,2006,3(6):446-449.
[7] 王洪武.肿瘤分子靶向治疗在实体肿瘤中的应用.中华医学信息导报,2006, 21(9):7-9.
[8] Wang H,Yu JM,Yang GR, et al.Further characterization of the epidermal growth factor receptor ligand 11C-PD 153035.Chin Med J (Engl),2007, 120(11):960-964.
[9] Geiovani JG.Molecular imaging of epidermal growth factor receptor expression-activity at the kinase level in tumors with positron emission tomography.Cancer Metastasis Rev,2008,27(4):645-653.
[10] Nordberg E,Orlova A,Friedman M,et al.In vivo and in vitrouptake of 111In,delivered with the affibody molecule(ZEGFR:955)2, in EGFR expressing tumour cells.Oncol Rep,2008,19(4):853-857.
[11] Gainkam LO,Huang L,Caveliers V,et al.Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice,using pinhole SPECT/micro-CT.J Nucl Med,2008,49(5):788-795.